Transgenic mouse models that explore the multistep hypothesis of intestinal neoplasia

SV-40 T antigen (TAg), human K-rasVal12, and a dominant negative mutant of human p53 (p53Ala143) have been expressed singly and in all possible combinations in postmitotic enterocytes distributed throughout the duodenal-colonic axis of 1-12-mo-old FVB/N transgenic mice to assess the susceptibility of this lineage to gene products implicated in the pathogenesis of human gut neoplasia. SV-40 TAg produces re-entry into the cell cycle. Transgenic pedigrees that produce K-rasVal12 alone, p53Ala143 alone, or K-rasVal12 and p53Ala143 have no detectable phenotypic abnormalities. However, K-rasVal12 cooperates with SV-40 TAg to generate marked proliferative and dysplastic changes in the intestinal epithelium. These abnormalities do not progress to form adenomas or adenocarcinomas over a 9-12-mo period despite sustained expression of the transgenes. Addition of p53Ala143 to enterocytes that synthesize SV-40 TAg and K-rasVal12 does not produce any further changes in proliferation or differentiation. Mice that carry one, two, or three of these transgenes were crossed to animals that carry Min, a fully penetrant, dominant mutation of the Apc gene associated with the development of multiple small intestinal and colonic adenomas. A modest (2-5-fold) increase in tumor number was noted in animals which express SV-40 TAg alone, SV-40 TAg and K-rasVal12, or SV-40 TAg, K-rasVal12 and p53Ala143. However, the histopathologic features of the adenomas were not altered and the gut epithelium located between tumors appeared similar to the epithelium of their single transgenic, bi-transgenic, or tri-transgenic parents without Min. These results suggest that (a) the failure of the dysplastic gut epithelium of SV-40 TAg X K-rasVal12 mice to undergo further progression to adenomas or adenocarcinomas is due to the remarkable protective effect of a continuously and rapidly renewing epithelium, (b) initiation of tumorigenesis in Min mice typically occurs in crypts rather than in villus-associated epithelial cell populations, and (c) transgenic mouse models of neoplasia involving members of the enterocytic lineage may require that gene products implicated in tumorigenesis be directed to crypt stem cells or their immediate descendants. Nonetheless, directing K-rasVal12 production to proliferating and nonproliferating cells in the lower and upper half of small intestinal and colonic crypts does not result in any detectable abnormalities.

[1]  R. Palmiter,et al.  Oncogene-induced liver neoplasia in transgenic mice. , 1989, Oncogene.

[2]  C. P. Leblond,et al.  Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. I. Columnar cell. , 1974, The American journal of anatomy.

[3]  J. Milner,et al.  Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation , 1991, Cell.

[4]  V. Rotter,et al.  Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells. , 1990, Oncogene.

[5]  William E. Grizzle,et al.  Detection of high incidence of K-ras oncogenes during human colon tumorigenesis , 1987, Nature.

[6]  J. Gordon,et al.  Spatial differentiation of the intestinal epithelium: analysis of enteroendocrine cells containing immunoreactive serotonin, secretin, and substance P in normal and transgenic mice. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[7]  K. Kinzler,et al.  Clues to the pathogenesis of familial colorectal cancer. , 1993, Science.

[8]  K. Kinzler,et al.  Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. , 1991, Science.

[9]  M. Lieberman,et al.  The use of antibodies to 5-bromo-2'-deoxyuridine for the isolation of DNA sequences containing excision-repair sites. , 1984, The Journal of biological chemistry.

[10]  S N Thibodeau,et al.  Microsatellite instability in cancer of the proximal colon. , 1993, Science.

[11]  M. Dobbelstein,et al.  Intracistronic complementation reveals a new function of SV40 T antigen that co-operates with Rb and p53 binding to stimulate DNA synthesis in quiescent cells. , 1992, Oncogene.

[12]  C. P. Leblond,et al.  Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. III. Entero-endocrine cells. , 1974, The American journal of anatomy.

[13]  M. Ashburner.  A Laboratory manual , 1989 .

[14]  M. Kedinger,et al.  Epithelial-mesenchymal interactions in intestinal epithelial differentiation. , 1988, Scandinavian journal of gastroenterology. Supplement.

[15]  K. Kinzler,et al.  Erratum: Multiple Intestinal Neoplasia Caused By a Mutation in the Murine Homolog of the APC Gene , 1992, Science.

[16]  M. Hermiston,et al.  Simultaneous localization of six antigens in single sections of transgenic mouse intestine using a combination of light and fluorescence microscopy. , 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[17]  J. Shay,et al.  A transcriptionally active DNA-binding site for human p53 protein complexes , 1992, Molecular and cellular biology.

[18]  B. Ponder,et al.  Cell migration pathway in the intestinal epithelium: An in situ marker system using mouse aggregation chimeras , 1985, Cell.

[19]  Margaret Robertson,et al.  Identification and characterization of the familial adenomatous polyposis coli gene , 1991, Cell.

[20]  T. Mohandas,et al.  The human and rodent intestinal fatty acid binding protein genes. A comparative analysis of their structure, expression, and linkage relationships. , 1987, The Journal of biological chemistry.

[21]  J. Gordon,et al.  The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system , 1992, The Journal of cell biology.

[22]  E. Unanue,et al.  Expression of membrane interleukin 1 by fibroblasts transfected with murine pro-interleukin 1 alpha cDNA. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Gordon,et al.  Studies of intestinal stem cells using normal, chimeric, and transgenic mice 1 , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  D. Ledbetter,et al.  Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. , 1989, Science.

[25]  M. Yaniv,et al.  Wild-type p53 can down-modulate the activity of various promoters. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Kastan,et al.  Wild-type p53 is a cell cycle checkpoint determinant following irradiation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[28]  D R Appleton,et al.  A comparison of cell proliferation at different sites within the large bowel of the mouse. , 1979, Journal of anatomy.

[29]  P. Friedman,et al.  Wild-type p53 activates transcription in vitro , 1992, Nature.

[30]  H. Hauri,et al.  Fetal gut mesenchyme induces differentiation of cultured intestinal endodermal and crypt cells. , 1986, Developmental biology.

[31]  B. Vogelstein,et al.  Clonal analysis of human colorectal tumors. , 1987, Science.

[32]  J. Gordon,et al.  Use of fetal intestinal isografts from normal and transgenic mice to study the programming of positional information along the duodenal-to-colonic axis. , 1992, The Journal of biological chemistry.

[33]  K. Kinzler,et al.  Definition of a consensus binding site for p53 , 1992, Nature Genetics.

[34]  Y. Qian,et al.  The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle , 1991, Cell.

[35]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[36]  J. Gordon,et al.  Temporal and spatial patterns of transgene expression in aging adult mice provide insights about the origins, organization, and differentiation of the intestinal epithelium. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Gordon,et al.  Use of transgenic mice to map cis-acting elements in the intestinal fatty acid binding protein gene (Fabpi) that control its cell lineage- specific and regional patterns of expression along the duodenal-colonic and crypt-villus axes of the gut epithelium , 1992, The Journal of cell biology.

[38]  J. Pipas,et al.  The large tumor antigen of simian virus 40 encodes at least two distinct transforming functions , 1989, Journal of virology.

[39]  P. Schmid,et al.  Expression of p53 during mouse embryogenesis. , 1991, Development.

[40]  L. Donehower,et al.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.

[41]  A. Levine,et al.  p53 mutations are not selected for in simian virus 40 T-antigen-induced tumors from transgenic mice , 1992, Journal of virology.

[42]  B. Vogelstein,et al.  p53 functions as a cell cycle control protein in osteosarcomas , 1990, Molecular and cellular biology.

[43]  Wen-Hwa Lee,et al.  SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene , 1988, Cell.

[44]  G. Williams,et al.  Demonstration of somatic mutation and colonic crypt clonality by X-linked enzyme histochemistry , 1988, Nature.

[45]  E. Appella,et al.  Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[46]  B. Vogelstein,et al.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia , 1992, Cell.

[47]  J. Gordon,et al.  Mapping enteroendocrine cell populations in transgenic mice reveals an unexpected degree of complexity in cellular differentiation within the gastrointestinal tract , 1990, The Journal of cell biology.

[48]  H Cheng,et al.  Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. IV. Paneth cells. , 1974, The American journal of anatomy.

[49]  J. Gordon,et al.  Use of transgenic mice to study the routing of secretory proteins in intestinal epithelial cells: analysis of human growth hormone compartmentalization as a function of cell type and differentiation [published erratum appears in J Cell Biol 1990 Jan;110(1):following 227] , 1989, The Journal of cell biology.

[50]  S. Altschul,et al.  Identification of FAP locus genes from chromosome 5q21. , 1991, Science.

[51]  M. Lemeur,et al.  H-ras induced transformation of mammary epithelium is favoured by increased oncogene expression or by inhibition of mammary regression. , 1991, Oncogene.

[52]  M. Kedinger,et al.  Importance of a fibroblastic support for in vitro differentiation of intestinal endodermal cells and for their response to glucocorticoids. , 1987, Cell differentiation.

[53]  K. Kinzler,et al.  Identification of p53 as a sequence-specific DNA-binding protein , 1991, Science.

[54]  J. Gordon,et al.  Use of transgenic mice to map cis-acting elements in the liver fatty acid-binding protein gene (Fabpl) that regulate its cell lineage-specific, differentiation-dependent, and spatial patterns of expression in the gut epithelium and in the liver acinus. , 1993, The Journal of biological chemistry.

[55]  M. Loeffler,et al.  Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. , 1990, Development.

[56]  C. P. Leblond,et al.  Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian Theory of the origin of the four epithelial cell types. , 1974, The American journal of anatomy.

[57]  R. Cardiff,et al.  v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[58]  J. Gordon,et al.  Expression of a liver fatty acid binding protein/human decay-accelerating factor/HLA-B44 chimeric gene in transgenic mice. , 1991, The American journal of physiology.

[59]  T. Pawson,et al.  High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene , 1989, Molecular and cellular biology.

[60]  Kathleen R. Cho,et al.  Identification of a chromosome 18q gene that is altered in colorectal cancers. , 1990, Science.

[61]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.

[62]  E. Appella,et al.  Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[63]  J. Gordon,et al.  Mechanisms underlying generation of gradients in gene expression within the intestine: an analysis using transgenic mice containing fatty acid binding protein-human growth hormone fusion genes. , 1988, Genes & development.

[64]  C. P. Leblond,et al.  Migration and turnover of entero-endocrine and caveolated cells in the epithelium of the descending colon, as shown by radioautography after continuous infusion of 3H-thymidine into mice. , 1979, The American journal of anatomy.

[65]  Bert Vogelstein,et al.  APC mutations occur early during colorectal tumorigenesis , 1992, Nature.

[66]  Cori Bargmann,et al.  Human colon carcinoma Ki-ras2 oncogene and its corresponding proto-oncogene , 1984, Molecular and cellular biology.

[67]  A. Levine,et al.  A mutant p53 protein is required for maintenance of the transformed phenotype in cells transformed with p53 plus ras cDNAs. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[68]  D. Lane,et al.  ras-Induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation , 1992, Cell.

[69]  T. Roderick,et al.  FVB/N: an inbred mouse strain preferable for transgenic analyses. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[70]  D. Drucker,et al.  Glucagon gene 5'-flanking sequences direct expression of simian virus 40 large T antigen to the intestine, producing carcinoma of the large bowel in transgenic mice. , 1992, The Journal of biological chemistry.

[71]  J. Pipas,et al.  T-antigen mutant activities in vivo: roles of p53 and pRB binding in tumorigenesis of the choroid plexus. , 1992, Oncogene.

[72]  P. Friedman,et al.  Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[73]  N. Wright,et al.  The kinetics of villus cell populations in the mouse small intestine , 1982, Cell and tissue kinetics.

[74]  A. Balmain,et al.  Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter , 1990, Cell.

[75]  J. Weber,et al.  Genetic mapping of a locus predisposing to human colorectal cancer. , 1993, Science.

[76]  T. Maimets,et al.  p53 interacts with p34cdc2 in mammalian cells: implications for cell cycle control and oncogenesis. , 1990, Oncogene.

[77]  H. Pitot,et al.  A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. , 1990, Science.

[78]  B. Vogelstein,et al.  Prevalence of ras gene mutations in human colorectal cancers , 1987, Nature.